Millennium Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Millennium Management's LKFT Position: Q2 2026 in Review
Millennium Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 68% in Q2 2026, buying an estimated $2.08M and bringing the position to 181,090 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2927.
Millennium Management first reported a position in LKFT in Q2 2015 and has held it in 36 quarters since. The position peaked at $19.5M in Q1 2022. 78 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Millennium Management held 181,090 shares of Lakefront Biotherapeutics American Depositary Shares worth $5.43M as of Q2 2026.
- Millennium Management bought 73,178 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $2.08M.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2927 holding.
- Millennium Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 36 quarters since.
- Millennium Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $19.5M in Q1 2022.
- 78 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.